Overview

Pharmacokinetic Evaluation of Serum Testosterone Concentrations After Administration of Clomiphene Citrate

Status:
Not yet recruiting

Trial end date:
2022-12-01

Target enrollment:

Participant gender:

Summary

This is a randomized, open-label trial examining two doses of clomiphene citrate in men with low serum testosterone concentrations (total testosterone (TT) < 300 ng/dl).

Phase:

Phase 2

Details

Lead Sponsor:

Weill Medical College of Cornell University

Treatments:

Citric Acid
Clomiphene
Enclomiphene
Sodium Citrate
Zuclomiphene